This process allows tumor antigens to be presented to T lymphocytes through the formation of MHC‐I complexes, promoting the proliferation of toxic T lymphocytes and infiltration of tumor sites.[138] RT promotes the delivery of TAAs and tumor DNA to DCs, which activates type I IFN production via the STING pathway.[139] Thus, RT stimulates a potential systemic immune response under the combined effects of innate and adaptive immunity. This evidence concerns the gene STING1 and neoplasm.